Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Moleculin Biotech Inc (NASDAQ: MBRX) closed the day trading at $0.5 down -5.66% from the previous closing price of $0.53. In other words, the price has decreased by -$5.66 from its previous closing price. On the day, 2.75 million shares were traded. MBRX stock price reached its highest trading level at $0.5314 during the session, while it also had its lowest trading level at $0.4766.
Ratios:
For a better understanding of MBRX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.15 and its Current Ratio is at 1.15.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 23 ’25 when Foster Jonathan P. bought 270,270 shares for $0.37 per share. The transaction valued at 100,000 led to the insider holds 287,587 shares of the business.
KLEMP WALTER V bought 675,675 shares of MBRX for $250,000 on Jun 23 ’25. The CEO and President now owns 743,607 shares after completing the transaction at $0.37 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MBRX now has a Market Capitalization of 24749288 and an Enterprise Value of 8006084.
Stock Price History:
The Beta on a monthly basis for MBRX is 1.58, which has changed by -0.7881356 over the last 52 weeks, in comparison to a change of 0.16766965 over the same period for the S&P500. Over the past 52 weeks, MBRX has reached a high of $3.65, while it has fallen to a 52-week low of $0.25. The 50-Day Moving Average of the stock is -4.59%, while the 200-Day Moving Average is calculated to be -47.16%.
Shares Statistics:
Over the past 3-months, MBRX traded about 5.56M shares per day on average, while over the past 10 days, MBRX traded about 3054240 shares per day. A total of 49.50M shares are outstanding, with a floating share count of 45.11M. Insiders hold about 8.87% of the company’s shares, while institutions hold 0.87% stake in the company. Shares short for MBRX as of 1757894400 were 2347632 with a Short Ratio of 0.42, compared to 1755216000 on 3297491. Therefore, it implies a Short% of Shares Outstanding of 2347632 and a Short% of Float of 6.59.
Earnings Estimates
. The current market rating for Moleculin Biotech Inc (MBRX) reflects the collective analysis of 3.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.26, with high estimates of -$0.13 and low estimates of -$0.42.
Analysts are recommending an EPS of between -$5.28 and -$5.28 for the fiscal current year, implying an average EPS of -$5.28. EPS for the following year is -$4.85, with 1.0 analysts recommending between -$4.85 and -$4.85.
